Novartis AG is considering a deal for radiopharmaceutical company Advanced Accelerator Applications SA (AAA), as the giant Swiss drugmaker seeks acquisitions to boost growth, people familiar with the matter said.
Novartis has approached AAA, as the company is known, about a deal and held talks, the people said, asking not to be identified because the deliberations are private.
AAA could also attract interest from other drugmakers, the people said.
No deal has been reached and talks may fall apart, the people said.
AAA’s US-listed shares rose as much as 17.6 percent to US$70.30 in after-hours trading. They have more than doubled this year through Wednesday’s close in New York, valuing the company at about US$2.6 billion.
Novartis shares have gained 11 percent in Switzerland year-to-date.
Representatives for Novartis and AAA declined to comment.
AAA makes radiopharmaceuticals, or radioactive drugs, used to diagnose and treat diseases, such as cancer. Italian academics founded the company in 2002 as a spinoff of the European Organization for Nuclear Research, or CERN. AAA is based in Saint-Genis-Pouilly, a French town just outside Geneva.
The company counts 21 production and research and development sites. It employs more than 530 people in 13 countries.
Novartis, which is hunting for assets to bolster its businesses in areas from cancer to cardiovascular disease, this month announced the surprise departure of CEO Joseph Jimenez after eight years at the helm of Europe’s largest drugmaker, handing off the challenge of selling underperforming assets and developing new medicines to Vasant Narasimhan, a Harvard-trained doctor.
Novartis has announced more than SU$30 billion in deals over the past four years, the largest being its 2015 acquisition of GlaxoSmithKline PLC’s oncology portfolio for as much as US$16 billion, according to data compiled by Bloomberg.
Jimenez has previously said the company is focusing on potential acquisitions of US$2 billion to US$5 billion.
The company has hired Keren Haruvi Snir from Teva Pharmaceutical Industries as its head of mergers and acquisitions, people familiar with the matter said.
To many, Tatu City on the outskirts of Nairobi looks like a success. The first city entirely built by a private company to be operational in east Africa, with about 25,000 people living and working there, it accounts for about two-thirds of all foreign investment in Kenya. Its low-tax status has attracted more than 100 businesses including Heineken, coffee brand Dormans, and the biggest call-center and cold-chain transport firms in the region. However, to some local politicians, Tatu City has looked more like a target for extortion. A parade of governors have demanded land worth millions of dollars in exchange
An Indonesian animated movie is smashing regional box office records and could be set for wider success as it prepares to open beyond the Southeast Asian archipelago’s silver screens. Jumbo — a film based on the adventures of main character, Don, a large orphaned Indonesian boy facing bullying at school — last month became the highest-grossing Southeast Asian animated film, raking in more than US$8 million. Released at the end of March to coincide with the Eid holidays after the Islamic fasting month of Ramadan, the movie has hit 8 million ticket sales, the third-highest in Indonesian cinema history, Film
Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) revenue jumped 48 percent last month, underscoring how electronics firms scrambled to acquire essential components before global tariffs took effect. The main chipmaker for Apple Inc and Nvidia Corp reported monthly sales of NT$349.6 billion (US$11.6 billion). That compares with the average analysts’ estimate for a 38 percent rise in second-quarter revenue. US President Donald Trump’s trade war is prompting economists to retool GDP forecasts worldwide, casting doubt over the outlook for everything from iPhone demand to computing and datacenter construction. However, TSMC — a barometer for global tech spending given its central role in the
Alchip Technologies Ltd (世芯), an application-specific integrated circuit (ASIC) designer specializing in server chips, expects revenue to decline this year due to sagging demand for 5-nanometer artificial intelligence (AI) chips from a North America-based major customer, a company executive said yesterday. That would be the first contraction in revenue for Alchip as it has been enjoying strong revenue growth over the past few years, benefiting from cloud-service providers’ moves to reduce dependence on Nvidia Corp’s expensive AI chips by building their own AI accelerator by outsourcing chip design. The 5-nanometer chip was supposed to be a new growth engine as the lifecycle
RSS